TPO and goiter: The most frequently cited determinant was the patient’s TSH level (32, 11.4%), followed by clinical symptoms (18, 6.4%) and adherence to guidelines (14, 5.0%), with other considerations such as TPO-Ab status, T4 level, and goiter presence each mentioned by around 11 (4.0%).